Velsera

Data is the cornerstone of modern genomics. Its power goes far beyond just generating results—it’s about uncovering insights that can reshape our understanding of complex diseases. In whole-genome sequencing (WGS) studies, rare variants in both coding and noncoding regions provide key clues about human health. By incorporating rich functional annotations, researchers can now identify associations that were once difficult to detect. Advanced computational tools, like the STAARpipeline, are helping to unlock the full potential of this data. By offering robust methods for analyzing rare variants across the genome, these tools not only improve the accuracy of results but also empower researchers to make faster, more informed decisions. The ability to harness data efficiently is essential to accelerating breakthroughs in precision medicine and rare disease research—ultimately leading to more personalized, effective treatments. Explore how data-driven approaches are transforming genomic research: https://lnkd.in/gWE3uRnD

Missed Our Posters at #AMPath2024? We’ve Got You Covered! Dive into the insights we shared at the event with downloadable versions of our posters, including: ?? Using a Knowledgebase of Clinical Assertions to Identify Potential Therapy Targets for Investigation in Underserved Cancers Get access to revolutionary research and see how our solutions are driving innovation in genomics and oncology. Download now: https://lnkd.in/gKZ45ZeS #AMP2024 #EraofVelsera #SilverSponsor #NGS #OncologyBreakthrough #DataDrivenCare

As NGS assays become more complex and generate larger #Datasets, laboratories face the critical challenge of ensuring the accuracy and quality of their data—especially when it comes to clinical decision support. We understand how important it is for labs to have the right tools to interpret this data effectively and make informed decisions for #PatientCare. That’s where CGW Plus comes in - our reimagined NGS workflow and reporting platform, designed to empower labs with a comprehensive curated knowledge base. By leveraging state-of-the-art clinical decision support, CGW Plus enables labs to efficiently manage and interpret complex genomic data, whether they’re running LDT or IVD assays. With CGW Plus, labs gain access to curated clinical content for each patient, ensuring they deliver the most accurate and relevant data for informed healthcare decisions. This innovation not only enhances the lab's workflow but also contributes to advancing precision medicine, driving better patient outcomes. We’re committed to equipping labs with the tools they need to stay at the forefront of genomic research, clinical reporting, and precision medicine. Together, we can bring data-driven #Healthcare to life.

Are you ready to discover the full potential of AI in bioinformatics? Discover how machine learning and AI can revolutionize your workflows and help tackle complex data challenges seamlessly. Register now for our webinar, “Leveraging Machine Learning and AI for Bioinformatics on the Seven Bridges Platform” and see how innovation can simplify your path to impactful discoveries. Don’t miss one of our limited spots – register here: https://lnkd.in/gAFyySA2 #EraofVelsera #AI #DrugDiscovery #WorkflowOptimization #Webinar

Struggling to extract actionable insights from your data? Discover the potential of RHEO. Building on the Seven Bridges Platform, RHEO offers a practical, immediate solution for productivity and quality control challenges by using automation to minimize the number of manual steps required to set up, run, and conclude an analysis. See RHEO in action and learn how it can accelerate your research. Explore more here: https://lnkd.in/g33_G3kf #EraofVelsera #WorkflowOptimization #DataDrivenScience

Time to Weigh In! What’s Holding Back Your NGS Reporting? As NGS testing evolves, clinical decision support is more important than ever. Vote below! Got challenges? We've got solutions. Watch our webinar today to learn how clinical decision support can elevate your lab’s reporting! Watch here: https://lnkd.in/gYTU8KYP #EraofVelsera #NGS #ClinicalSupport #LabChallenges

?? Live from the #AMPath2024 Show Floor! We’re popping with excitement at Booth 1319—literally! Stop by for some fresh popcorn and stay for groundbreaking insights into the future of genomics. Let’s chat about how we can help you unlock new possibilities in your lab. See you there! #AMP2024 #EraofVelsera #SilverSponsor #NGS #OncologyBreakthrough #DataDrivenCare

Today, on World Pancreatic Cancer Day, we stand with patients, caregivers, and researchers dedicated to improving outcomes for this complex disease. At Velsera, we're honored to support groundbreaking work like our partner Pancreatic Cancer Action Network (PanCan), which is advancing precision genomics to drive impactful discoveries in pancreatic cancer research. Together, we can progress toward earlier detection, better treatments, and hope for those affected. PanCAN’s SPARK platform (https://lnkd.in/g7WcQ3n4) integrates real-world patient health data from PanCAN research initiatives and accelerates research by making pancreatic cancer data easier to access and use. Join us in spreading awareness, sharing knowledge, and supporting those affected by pancreatic cancer. Let's change the course of pancreatic cancer and create a world in which all pancreatic cancer patients thrive. #PanCanawareness #CancerResearch #DrugDiscovery

Velsera is proud to be a key collaborator with Illumina in advancing next-generation sequencing (NGS) technologies, as highlighted in this latest announcement. Together, we're driving innovation and accessibility in precision genomics, empowering scientists and clinicians worldwide to push the boundaries of discovery and improve patient outcomes.? ? Check out the full press release here: https://lnkd.in/gj9KzrT2 ? #EraofVelsera #PrecisionGenomics #Collaboration #Innovation

Researchers analyzed over 10,000 tumors across 33 cancer types using TCGA data, revealing six immune subtypes that impact tumor-immune interactions, driver mutations, and prognosis. The advanced analyses in this study utilized multi-omics pipelines and data from NCI’s Cancer Research Data Commons, including the Seven Bridges-powered platform Cancer Genomics Cloud, providing a resource to drive future targeted research. Read to learn more here: https://lnkd.in/gud2KDFF #EraofVelsera #Discovery #Cancer #Publication